Incyte appointed Bill Meury as the new CEO on June 27, 2025, causing the company's stock to rise.
2 reports, 0 independent
Updated Jun 27
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Incyte appointed Bill Meury as the new CEO on June 27, 2025, causing the company's stock to rise.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Incyte leadership change: Bill Meury appointed CEO.
- Meury's appointment is contextualized by his prior experience at Karuna and Allergan.
Keep exploring
The entities involved
-
Incyte
American pharmaceutical company
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet